We are live on ! Find out more
Clearstead Advisors

Clearstead Advisors Portfolio holdings

AUM $10.6B Turnover 42.91%
1-Year Est. Return 24.87%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+24.87%
3 Year Est. Return
+71.44%
5 Year Est. Return
+80.35%
10 Year Est. Return
–
AUM
$10.6B
AUM Growth
-$353M
Cap. Flow
-$277M
Cap. Flow %
-2.62%
Top 10 Hldgs %
28.93%
Holding
3,754
New
1,518
Increased
1,198
Reduced
637
Closed
93
Avg Time Held Equity + Options
2 years
Top 10 Avg Time Held Equity + Options
3 years
Top 20 Avg Time Held Equity + Options
3 years
Avg Time Held Equity only
2 years
Top 10 Avg Time Held Equity only
3 years
Top 20 Avg Time Held Equity only
3.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 61.29%
2 Technology 11.98%
3 Industrials 7.46%
4 Financials 5.38%
5 Consumer Discretionary 3.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MNTK icon
3601
Montauk Renewables
MNTK
$316M
$15 ﹤0.01%
+9
New +$13
2026 Q2
0 quarters
NEWT icon
3602
NewtekOne
NEWT
$319M
$15 ﹤0.01%
+1
New +$13
2026 Q2
0 quarters
PAMT icon
3603
PAMT Corp
PAMT
$245M
$15 ﹤0.01%
+1
New +$12
2026 Q2
0 quarters
HLLY icon
3604
Holley
HLLY
$310M
$14 ﹤0.01%
+5
New +$14
2026 Q2
0 quarters
LVWR icon
3605
LiveWire
LVWR
$318M
$14 ﹤0.01%
+11
New +$17
2026 Q2
0 quarters
TTEC icon
3606
TTEC Holdings
TTEC
$76.4M
$14 ﹤0.01%
+7
New +$18
2026 Q2
0 quarters
NAGE icon
3607
Niagen Bioscience
NAGE
$200M
$14 ﹤0.01%
+4
New +$16
2026 Q2
0 quarters
ASPI icon
3608
ASP Isotopes
ASPI
$336M
$13 ﹤0.01%
+2
New +$12
2026 Q2
0 quarters
IKT icon
3609
Inhibikase Therapeutics
IKT
$251M
$13 ﹤0.01%
+6
New +$11
2026 Q2
0 quarters
RCEL icon
3610
Avita Medical
RCEL
$410M
$13 ﹤0.01%
+3
New +$13
2026 Q2
0 quarters
WALD icon
3611
DELISTED
Waldencast
WALD
$13 ﹤0.01%
+7
New +$9
2026 Q2
0 quarters
RZLV icon
3612
Rezolve AI
RZLV
$742M
$13 ﹤0.01%
+4
New +$11
2026 Q2
0 quarters
TARA icon
3613
Protara Therapeutics
TARA
$143M
$12 ﹤0.01%
+3
New +$14
2026 Q2
0 quarters
WBTN icon
3614
WEBTOON Entertainment Inc
WBTN
$1.21B
$12 ﹤0.01%
+1
New +$12
2026 Q2
0 quarters
AFRI icon
3615
Forafric Global
AFRI
$324M
$11 ﹤0.01%
+1
New +$10
2026 Q2
0 quarters
EXFY icon
3616
Expensify
EXFY
$222M
$11 ﹤0.01%
+6
New +$7
2026 Q2
0 quarters
GAME icon
3617
GameSquare
GAME
$34.4M
$11 ﹤0.01%
3
– –
2024 Q1
9 quarters
SPOK icon
3618
Spok Holdings
SPOK
$225M
$11 ﹤0.01%
+1
New +$11
2026 Q2
0 quarters
ARAY icon
3619
Accuray
ARAY
$19.5M
$10 ﹤0.01%
+33
New +$12
2026 Q2
0 quarters
LAB icon
3620
Standard BioTools
LAB
$251M
$10 ﹤0.01%
+11
New +$10
2026 Q2
0 quarters
HURA icon
3621
TuHURA Biosciences
HURA
$116M
$10 ﹤0.01%
+4
New +$9
2026 Q2
0 quarters
MH icon
3622
McGraw Hill
MH
$2.66B
$10 ﹤0.01%
+1
New +$12
2026 Q2
0 quarters
SEVN icon
3623
Seven Hills Realty Trust
SEVN
$157M
$9 ﹤0.01%
+1
New +$8
2026 Q2
0 quarters
TRAK icon
3624
ReposiTrak
TRAK
$131M
$9 ﹤0.01%
+1
New +$9
2026 Q2
0 quarters
VUZI icon
3625
Vuzix
VUZI
$185M
$9 ﹤0.01%
+3
New +$9
2026 Q2
0 quarters

Similar funds

Clearstead Advisors's Q2 2026 Portfolio in Review

As of Q2 2026, Clearstead Advisors held 3,754 positions worth $10.6B, down 3.2% from $10.9B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Clearstead Advisors's Q2 2026 filing shows 1,518 new, 1,198 increased, 637 reduced and 93 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M. The largest sale was PACCAR, an estimated $287M.

By sector, the portfolio is most concentrated in Miscellaneous at 61% of assets, up from 61% a quarter earlier, followed by Technology and Industrials.

  • Clearstead Advisors's largest Q2 2026 buy was Vanguard S&P 500 ETF: 1,450,939 shares worth $997M.
  • Clearstead Advisors added most to Sonoco in Q2 2026, an estimated $35.5M increase.
  • Clearstead Advisors's biggest Q2 2026 reduction was PACCAR, cutting an estimated $287M.
  • Clearstead Advisors fully exited iShares Currency Hedged MSCI Japan ETF in Q2 2026, selling an estimated $9.02M.
  • Clearstead Advisors's ten largest holdings make up 29% of its $10.6B portfolio in Q2 2026.
  • Clearstead Advisors opened 1,518 new positions and closed 93 in Q2 2026.
  • Clearstead Advisors's portfolio value fell 3.2% quarter-over-quarter to $10.6B.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.